Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Phase II Chemoprevention Study of Iloprost Versus Placebo in Patients at High Risk for Lung Cancer

NCT00084409 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT00084409
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00084409 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Phase II Chemoprevention Study of Iloprost Versus Placebo in Patients at High Risk for Lung Cancer
Lead sponsor
University of Colorado, Denver
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2001
Completion date
January 31, 2009
Enrollment
152 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer, precancerous condition